O uso de Zolpidem para tratamento de insônia
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/1289 |
Resumo: | More than 73 million Brazilians suffer from insomnia, mainly in the country's large centers. Among the main causes of this problem are stress, anxiety, irregular sleeping habits, lifestyle and use of screens (cell phone, TV, etc.) at night. To treat this problem, many doctors prescribe zolpidem to their patients, as the medication is used to treat this sleep disorder. This research aimed to evaluate the use of zolpidem as a non-benzoadizepine sedative-hypnotic prescribed for insomnia. To this end, an exploratory research was carried out, a questionnaire for data collection with 12 questions was formulated and applied to 100 people, by form, who already use zolpidem. Of these participants, the majority were women (72%), the majority were between 25 and 35 years old (36%) and the majority had been using the medication for more than 1 year (58%). The majority reported an improvement in sleep quality after using the medication (97%) and the majority did not need to increase the medication dose (75%). Furthermore, the majority rarely forgot to administer the medication (76%), the majority never stopped administering it due to symptom improvement (71%) or worsening (92%) and the majority never administered the medication on their own (71% ). The majority administer another medication along with zolpidem (80%), the majority did not have any adverse reactions (74%), the majority did not attempt to wean off the medication (80%) and the majority never provided pills to people close to them (91% ). It is concluded that zolpidem is safe to treat sleep disorders with medical advice, and prolonged use should be avoided to avoid possible adverse reactions and dependence. The need for individualized assessment of each patient is evident. Keywords: 1. Zolpidem. 2. Insomnia. 3. Adverse reactions. 4. Medicine. 5. Sleep. |
id |
GOE-1_71d104a9e9c8979f405532828f0b34e7 |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/1289 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
repository_id_str |
|
spelling |
O uso de Zolpidem para tratamento de insônia ZolpidemInsôniaReações AdversasMedicamentoSonoMore than 73 million Brazilians suffer from insomnia, mainly in the country's large centers. Among the main causes of this problem are stress, anxiety, irregular sleeping habits, lifestyle and use of screens (cell phone, TV, etc.) at night. To treat this problem, many doctors prescribe zolpidem to their patients, as the medication is used to treat this sleep disorder. This research aimed to evaluate the use of zolpidem as a non-benzoadizepine sedative-hypnotic prescribed for insomnia. To this end, an exploratory research was carried out, a questionnaire for data collection with 12 questions was formulated and applied to 100 people, by form, who already use zolpidem. Of these participants, the majority were women (72%), the majority were between 25 and 35 years old (36%) and the majority had been using the medication for more than 1 year (58%). The majority reported an improvement in sleep quality after using the medication (97%) and the majority did not need to increase the medication dose (75%). Furthermore, the majority rarely forgot to administer the medication (76%), the majority never stopped administering it due to symptom improvement (71%) or worsening (92%) and the majority never administered the medication on their own (71% ). The majority administer another medication along with zolpidem (80%), the majority did not have any adverse reactions (74%), the majority did not attempt to wean off the medication (80%) and the majority never provided pills to people close to them (91% ). It is concluded that zolpidem is safe to treat sleep disorders with medical advice, and prolonged use should be avoided to avoid possible adverse reactions and dependence. The need for individualized assessment of each patient is evident. Keywords: 1. Zolpidem. 2. Insomnia. 3. Adverse reactions. 4. Medicine. 5. Sleep.Mais de 73 milhões de brasileiros sofrem com insônia, principalmente nos grandes centros do país. Entre as principais causas para esse problema estão o estresse, ansiedade, hábitos de sono irregulares, estilo de vida e uso de telas (celular, TV etc.) no período noturno. Para o tratamento desse problema, muitos médicos prescrevem o zolpidem para seus pacientes, visto que o medicamento serve para o tratamento desse distúrbio do sono. Essa pesquisa visou avaliar o uso do medicamento zolpidem como um sedativo-hipnótico não benzoadizepínico prescrito para insônia. Para isso foi feito uma pesquisa exploratória, formulado um questionário para levantamento de dados com 12 perguntas e aplicado a 100 pessoas, via formulário, que já fazem uso do zolpidem. Destes participantes, a maioria foram mulheres (72%), a maioria tem entre 25 e 35 anos (36%) e a maioria faz uso do medicamento a mais de 1 ano (58%). A maioria relatou melhoria na qualidade do sono após o uso do medicamento (97%) e a maioria não teve necessidade de aumento da dose do medicamento (75%). Além disso, a maioria raramente esqueceu de administrar o medicamento (76%), a maioria nunca deixou de administrar por melhora dos sintomas (71%) ou por piora (92%) e a maioria nunca administrou o medicamento por conta própria (71%). A maioria administra outro medicamento junto com o zolpidem (80%), a maioria não teve nenhuma reação adversa (74%), a maioria não tentou o desmame do medicamento (80%) e a maioria nunca forneceu comprimidos para pessoas próximas (91%). Conclui-se que o zolpidem é seguro para tratar distúrbios do sono com orientações médicas, devendo ser evitado o uso prolongado para evitar possíveis reações adversas e dependência. Fica evidente a necessidade de avaliação individualizada de cada paciente. Palavras-chave: 1. Zolpidem. 2. Insônia. 3. Reações adversas. 4. Medicamento. 5. Sono.Specialized Dentistry Group2024-01-25info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/128910.36557/2674-8169.2024v6n1p1806-1823Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 1 (2024): BJIHS QUALIS B3; 1806-1823Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 1 (2024): BJIHS QUALIS B3; 1806-1823Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 1 (2024): BJIHS QUALIS B3; 1806-18232674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1289/1507Copyright (c) 2024 Yara Fernanda Oliveira Goulart , Júlia Pizzo Pereira, Ingrid de Oliveira Silva , Victoria Gastaldelo , Thainá Cruz Magalhães , Ingrid Pedroso Ribeiro , Danyelle Cristine Marinihttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFernanda Oliveira Goulart , YaraPizzo Pereira, Júliade Oliveira Silva , IngridGastaldelo , VictoriaCruz Magalhães , ThaináPedroso Ribeiro , IngridCristine Marini, Danyelle2024-01-25T19:55:19Zoai:ojs.bjihs.emnuvens.com.br:article/1289Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2024-01-25T19:55:19Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
O uso de Zolpidem para tratamento de insônia |
title |
O uso de Zolpidem para tratamento de insônia |
spellingShingle |
O uso de Zolpidem para tratamento de insônia Fernanda Oliveira Goulart , Yara Zolpidem Insônia Reações Adversas Medicamento Sono |
title_short |
O uso de Zolpidem para tratamento de insônia |
title_full |
O uso de Zolpidem para tratamento de insônia |
title_fullStr |
O uso de Zolpidem para tratamento de insônia |
title_full_unstemmed |
O uso de Zolpidem para tratamento de insônia |
title_sort |
O uso de Zolpidem para tratamento de insônia |
author |
Fernanda Oliveira Goulart , Yara |
author_facet |
Fernanda Oliveira Goulart , Yara Pizzo Pereira, Júlia de Oliveira Silva , Ingrid Gastaldelo , Victoria Cruz Magalhães , Thainá Pedroso Ribeiro , Ingrid Cristine Marini, Danyelle |
author_role |
author |
author2 |
Pizzo Pereira, Júlia de Oliveira Silva , Ingrid Gastaldelo , Victoria Cruz Magalhães , Thainá Pedroso Ribeiro , Ingrid Cristine Marini, Danyelle |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Fernanda Oliveira Goulart , Yara Pizzo Pereira, Júlia de Oliveira Silva , Ingrid Gastaldelo , Victoria Cruz Magalhães , Thainá Pedroso Ribeiro , Ingrid Cristine Marini, Danyelle |
dc.subject.por.fl_str_mv |
Zolpidem Insônia Reações Adversas Medicamento Sono |
topic |
Zolpidem Insônia Reações Adversas Medicamento Sono |
description |
More than 73 million Brazilians suffer from insomnia, mainly in the country's large centers. Among the main causes of this problem are stress, anxiety, irregular sleeping habits, lifestyle and use of screens (cell phone, TV, etc.) at night. To treat this problem, many doctors prescribe zolpidem to their patients, as the medication is used to treat this sleep disorder. This research aimed to evaluate the use of zolpidem as a non-benzoadizepine sedative-hypnotic prescribed for insomnia. To this end, an exploratory research was carried out, a questionnaire for data collection with 12 questions was formulated and applied to 100 people, by form, who already use zolpidem. Of these participants, the majority were women (72%), the majority were between 25 and 35 years old (36%) and the majority had been using the medication for more than 1 year (58%). The majority reported an improvement in sleep quality after using the medication (97%) and the majority did not need to increase the medication dose (75%). Furthermore, the majority rarely forgot to administer the medication (76%), the majority never stopped administering it due to symptom improvement (71%) or worsening (92%) and the majority never administered the medication on their own (71% ). The majority administer another medication along with zolpidem (80%), the majority did not have any adverse reactions (74%), the majority did not attempt to wean off the medication (80%) and the majority never provided pills to people close to them (91% ). It is concluded that zolpidem is safe to treat sleep disorders with medical advice, and prolonged use should be avoided to avoid possible adverse reactions and dependence. The need for individualized assessment of each patient is evident. Keywords: 1. Zolpidem. 2. Insomnia. 3. Adverse reactions. 4. Medicine. 5. Sleep. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-01-25 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1289 10.36557/2674-8169.2024v6n1p1806-1823 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/1289 |
identifier_str_mv |
10.36557/2674-8169.2024v6n1p1806-1823 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1289/1507 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 1 (2024): BJIHS QUALIS B3; 1806-1823 Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 1 (2024): BJIHS QUALIS B3; 1806-1823 Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 1 (2024): BJIHS QUALIS B3; 1806-1823 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1796798443670208512 |